US equities
|
NVDA
$237.15
▲+1.37%
SPCX
$165.17
▲+3.91%
MU
$1,063.14
▼-1.09%
TSLA
$378.11
▲+2.03%
MSFT
$526.31
▲+1.70%
INTC
$116.36
▼-2.49%
SNDK
$1,720.66
▲+0.04%
AMD
$628.00
▼-0.93%
NVDA
$237.15
▲+1.37%
SPCX
$165.17
▲+3.91%
MU
$1,063.14
▼-1.09%
TSLA
$378.11
▲+2.03%
MSFT
$526.31
▲+1.70%
INTC
$116.36
▼-2.49%
SNDK
$1,720.66
▲+0.04%
AMD
$628.00
▼-0.93%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Precigen, Inc.
Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers
August 25, 2026
From
Precigen, Inc.
Via
ACCESS Newswire
Tickers
PGEN